IP Library Granted Patent US 7,385,052
Granted Patent B2
US 7,385,052 · App. 09/920,286 · Granted Jun 10, 2008

Process for the production of multiple cross-linked hyaluronic acid derivatives

Assignee: Mentor Biopolymers Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,385,052
App. No.
09/920,286
Granted
Jun 10, 2008
Kind
B2
Abstract

The present invention relates to a process for the production of cross-linked hyaluronic acid (HA) derivatives, in particular multiple, e.g. double cross-linked hyaluronic acid derivatives. The invention also provides novel cross-linked HA derivatives, products containing them and their uses in medical and pharmaceutical and cosmetic applications.

Claims (16)

1. A process for the preparation of multiple cross-linked hyaluronic acid (HA), which process comprises covalently cross-linking HA via two or more different functional groups, wherein said cross-linking is effected by contacting HA with one or more chemical cross-linking agents so as to form two or more different types of functional bonds between HA molecules, wherein said two or more different types of functional bonds are selected from the group consisting of ether, ester, sulfone, amine, imino, and amide bonds, and wherein an ether bond is formed using a glutaraldehyde cross-linking agent under acidic conditions.

2. A process for the preparation of multiple cross-linked HA, which process comprises covalently cross-linking HA via two or more different functional groups, wherein said cross-linking is effected by contacting HA with one or more chemical cross-linking agents so as to form two or more different types of functional bonds between HA molecules, wherein said two or more different types of functional bonds are selected from the group consisting of ether, sulfone, amine, imino, and amide bonds.

3. A process according to claim 2 , wherein at least one functional bond is an ether bond formed using a cross-linking agent selected from the group consisting of bis epoxides and poly epoxides under alkaline conditions.

4. A process according to claim 2 , wherein the cross-linking agent is 1,2,3,4-diepoxybutane or 1,2,7,8-diepoxyoctane.

5. A process for the preparation of multiple cross-linked HA, which process comprises covalently cross-linking HA via two or more different functional groups, wherein said cross-linking is effected by contacting HA with one or more chemical cross-linking agents so as to form two or more different types of functional bonds between HA molecules, wherein said two or more different types of functional bonds are selected from the group consisting of ester, sulfone, amine, imino, and amide bonds.

6. A process according to claim 5 , wherein at least one functional bond is an ester bond formed using a cross-linking agent selected from the group consisting of bis epoxides and poly epoxides under acidic conditions.

7. A process according to claim 5 , wherein the cross-linking agent is 1,2,3,4-diepoxybutane or 1,2,7,8-diepoxyoctane.

8. A process for the preparation of multiple cross-linked HA, which process comprises covalently cross-linking HA via two or more different functional groups, wherein said cross-linking is effected by contacting HA with one or more chemical cross-linking agents so as to form two or more different types of functional bonds between HA molecules, wherein said two or more different types of functional bonds are selected from the group consisting of ether, ester, sulfone, amine, imino, and amide bonds, and wherein said process comprises contacting said HA with a first cross-linking agent in a reaction mixture so as to form a first type of functional bond, and adding to said reaction mixture a further amount of said first cross-linking agent or a second cross-linking agent so as to form a second type of functional bond.

9. A process according to claim 8 , wherein said HA is contacted with said first cross-linking agent under alkaline conditions.

10. A process according to claim 9 , wherein said first cross-linking agent is a bis epoxide or a poly epoxide.

11. A process according to claim 9 , wherein said first cross-linking agent is 1,2,3,4-diepoxybutane or 1,2,7,8-diepoxyoctane.

12. A process according to claim 8 , wherein said first cross-linking agent is a bis epoxide or a poly epoxide, and wherein said second cross-linking agent is glutaraldehyde.

13. A process according to claim 8 , wherein the cross-linking of each type of functional group is effected sequentially.

14. A process according to claim 8 , wherein the cross-linking of each type of functional group is effected simultaneously.

15. A process according to claim 8 , comprising adding to said reaction mixture a second cross-linking agent so as to form a second type of functional bond.

16. A process according to claim 9 , further comprising adding a further amount of said first cross-linking agent to said reaction medium under acidic conditions.

Assignments (4)
CHANGE OF NAME Recorded Mar 4, 2010
From: MENTOR CORPORATION
To: MENTOR WORLDWIDE LLC
Reel/Frame 024023/0607 →
CHANGE OF NAME Recorded Jul 7, 2004
From: A-LIFE LIMITED
To: MENTOR BIOPOLYMERS LIMITED
Reel/Frame 015545/0117 →
CHANGE OF NAME Recorded Feb 24, 2003
From: VITROLIFE UK LIMITED
To: A-LIFE LIMITED
Reel/Frame 013788/0286 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 2, 2002
From: ZHAO, XIAOBIN
To: VITROLIFE UK LIMITED
Reel/Frame 012427/0746 →
Priority Claims (1)
GB 9902412 · Feb 3, 1999 · national
Continuity (2)
Continuation PCTGB000032100 · Feb 3, 2000
Related Publication 20020091251A1 · Jul 11, 2002